Rasagilin Sandoz 1 mg - Tabletten
Recall
|
Medicines
|
13/06/2022
The marketing authorisation holder informed its customers on June 13, 2022 that the nitrosamine levels of the listed batch is above the permitted acceptable daily dose.
As a precautionary measure, the affected batch is recalled.
| Name of the medicinal product | Rasagilin Sandoz 1 mg - Tabletten |
|---|---|
| Marketing authorisation number(s) | 136653 |
| CIP code | 4229596 |
| Marketing authorisation holder | Sandoz GmbH |
| Batch number(s) | JZ6984 |
| Expiry date | 02/28/2023 |
| Classification of the recall | 2 |
| Depth of recall | Pharmacies |
| BASG reference number | INS-640.001-3905 |
Further inquiry note
Page last modified:
13/06/2022